{"id":"https://openalex.org/W2172137232","doi":"https://doi.org/10.1128/aac.50.4.1170-1177.2006","title":"Determinants of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol Pharmacokinetics in a Cohort of Tuberculosis Patients","display_name":"Determinants of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol Pharmacokinetics in a Cohort of Tuberculosis Patients","publication_year":2006,"publication_date":"2006-03-28","ids":{"openalex":"https://openalex.org/W2172137232","doi":"https://doi.org/10.1128/aac.50.4.1170-1177.2006","mag":"2172137232","pmid":"https://pubmed.ncbi.nlm.nih.gov/16569826","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1426981"},"language":"en","primary_location":{"id":"doi:10.1128/aac.50.4.1170-1177.2006","doi":"https://doi.org/10.1128/aac.50.4.1170-1177.2006","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.50.4.1170-1177.2006","pdf_url":"https://aac.asm.org/content/aac/50/4/1170.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aac.asm.org/content/aac/50/4/1170.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025069184","display_name":"Helen McIlleron","orcid":"https://orcid.org/0000-0002-0982-6226","observed_orcids":["https://orcid.org/0000-0002-0982-6226"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Helen McIlleron","raw_affiliation_strings":["Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086010206","display_name":"Peter Wash","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Wash","raw_affiliation_strings":["Brewelskloof Hospital, Worcester, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brewelskloof Hospital, Worcester, South Africa","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073520677","display_name":"Andr\u00e9 Burger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andre\u0301 Burger","raw_affiliation_strings":["Brewelskloof Hospital, Worcester, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brewelskloof Hospital, Worcester, South Africa","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059101690","display_name":"Jennifer Norman","orcid":"https://orcid.org/0000-0002-6903-6031","observed_orcids":["https://orcid.org/0000-0002-6903-6031"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Jennifer Norman","raw_affiliation_strings":["Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114007898","display_name":"Peter Ian Folb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I10947320","display_name":"South African Medical Research Council","ror":"https://ror.org/05q60vz69","country_code":"ZA","type":"other","lineage":["https://openalex.org/I10947320"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Peter I. Folb","raw_affiliation_strings":["Medical Research Council of South Africa, Tygerberg, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Research Council of South Africa, Tygerberg, South Africa","institution_ids":["https://openalex.org/I10947320"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108474818","display_name":"Pete Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Pete Smith","raw_affiliation_strings":["Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.7773,"has_fulltext":false,"cited_by_count":246,"citation_normalized_percentile":{"value":0.97213195,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"50","issue":"4","first_page":"1170","last_page":"1177"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.6563000082969666,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.6563000082969666,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.23489999771118164,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.09109999984502792,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.796999990940094},{"id":"https://openalex.org/keywords/isoniazid","display_name":"isoniazid","score":1.0},{"id":"https://openalex.org/keywords/pyrazinamide","display_name":"pyrazinamide","score":1.0},{"id":"https://openalex.org/keywords/ethambutol","display_name":"ethambutol","score":1.0},{"id":"https://openalex.org/keywords/antituberculosis-drugs","display_name":"antitubercular agents","score":0.8500000238418579},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8360000252723694},{"id":"https://openalex.org/keywords/pharmacokinetic-variability","display_name":"pharmacokinetic variability","score":0.8339999914169312},{"id":"https://openalex.org/keywords/pulmonary-tuberculosis","display_name":"pulmonary tuberculosis","score":0.8190000057220459},{"id":"https://openalex.org/keywords/hiv-coinfection","display_name":"HIV coinfection","score":0.8830000162124634},{"id":"https://openalex.org/keywords/pharmaceutical-formulations","display_name":"drug formulation","score":0.7260000109672546},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.9509999752044678},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.6790000200271606},{"id":"https://openalex.org/keywords/age-effects","display_name":"age effects","score":0.7689999938011169},{"id":"https://openalex.org/keywords/area-under-the-concentration-time-curve","display_name":"area under the concentration-time curve","score":0.7269999980926514},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.6000000238418579}],"concepts":[{"id":"https://openalex.org/C2776228421","wikidata":"https://www.wikidata.org/wiki/Q412318","display_name":"Ethambutol","level":4,"score":0.9791079163551331},{"id":"https://openalex.org/C2780459521","wikidata":"https://www.wikidata.org/wiki/Q417571","display_name":"Pyrazinamide","level":4,"score":0.9393466711044312},{"id":"https://openalex.org/C2776967927","wikidata":"https://www.wikidata.org/wiki/Q423169","display_name":"Isoniazid","level":3,"score":0.8739631175994873},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7679564356803894},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6859424114227295},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.6523119211196899},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5637176036834717},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4994382858276367},{"id":"https://openalex.org/C2778607973","wikidata":"https://www.wikidata.org/wiki/Q422652","display_name":"Rifampicin","level":3,"score":0.4757799208164215},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4385015368461609},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07002058625221252}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004977","descriptor_name":"Ethambutol","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007538","descriptor_name":"Isoniazid","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011718","descriptor_name":"Pyrazinamide","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014376","descriptor_name":"Tuberculosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014376","descriptor_name":"Tuberculosis","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1128/aac.50.4.1170-1177.2006","doi":"https://doi.org/10.1128/aac.50.4.1170-1177.2006","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.50.4.1170-1177.2006","pdf_url":"https://aac.asm.org/content/aac/50/4/1170.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1426981","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1426981","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:16569826","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16569826","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1128/aac.50.4.1170-1177.2006","doi":"https://doi.org/10.1128/aac.50.4.1170-1177.2006","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.50.4.1170-1177.2006","pdf_url":"https://aac.asm.org/content/aac/50/4/1170.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8600000143051147,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2172137232.pdf"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1522302756","https://openalex.org/W1564336530","https://openalex.org/W1867048120","https://openalex.org/W1976696095","https://openalex.org/W2008329752","https://openalex.org/W2009816311","https://openalex.org/W2011863437","https://openalex.org/W2042333540","https://openalex.org/W2061399828","https://openalex.org/W2072475014","https://openalex.org/W2075714353","https://openalex.org/W2078363932","https://openalex.org/W2082601094","https://openalex.org/W2089663335","https://openalex.org/W2095396294","https://openalex.org/W2097210644","https://openalex.org/W2120761149","https://openalex.org/W2121763061","https://openalex.org/W2139724863","https://openalex.org/W2144692033","https://openalex.org/W2152189184","https://openalex.org/W2170452898","https://openalex.org/W2398732098","https://openalex.org/W2400238344","https://openalex.org/W2402563982","https://openalex.org/W2409045489","https://openalex.org/W2411171235","https://openalex.org/W2462303025","https://openalex.org/W2473896701"],"related_works":["https://openalex.org/W2508477945","https://openalex.org/W1968194776","https://openalex.org/W2082601094","https://openalex.org/W2163094860","https://openalex.org/W4280495818","https://openalex.org/W2592851271","https://openalex.org/W7071034912","https://openalex.org/W7096164989","https://openalex.org/W2809469513","https://openalex.org/W2124299334"],"abstract_inverted_index":{"Evaluation":[0],"of":[1,3,9,15,18,21,39,48,61,71,84,112,156,178,186,199,207,219],"sources":[2,17],"pharmacokinetic":[4,62],"variation":[5,19,111],"can":[6],"facilitate":[7],"optimization":[8],"tuberculosis":[10,49,80],"treatment":[11,54,86,107,189],"regimens":[12,55],"by":[13,93],"identification":[14],"avoidable":[16],"and":[20,43,56,105,144,149,158,166,180,194,227],"risk":[22],"factors":[23,108,125,153],"for":[24,69,147,225],"low":[25],"or":[26],"high":[27],"drug":[28,132,223],"concentrations":[29,133,168,206,224],"in":[30,45,74,87,130,221,238],"patients.":[31],"Our":[32],"objective":[33],"was":[34,99,140,202],"to":[35,57,101,121,215,233],"describe":[36],"the":[37,59,72,103,106,113,116,195,205,217,235],"pharmacokinetics":[38],"rifampin,":[40],"isoniazid,":[41],"pyrazinamide,":[42],"ethambutol":[44,171,192],"a":[46,184],"cohort":[47],"patients":[50,76,162,174,182,239],"established":[51],"on":[52],"first-line":[53],"evaluate":[58,102],"determinants":[60,155],"variation.":[63],"Plasma":[64],"concentration-time":[65,117],"profiles":[66],"were":[67,91,134,154],"determined":[68],"each":[70],"drugs":[73],"142":[75],"with":[77,110,128,142,183,204],"drug-sensitive":[78],"pulmonary":[79],"after":[81],"2":[82],"months":[83],"daily":[85],"hospital.":[88],"Pharmacokinetic":[89],"measures":[90],"described":[92],"noncompartmental":[94],"analysis.":[95],"Multiple":[96],"linear":[97],"regression":[98],"used":[100],"patient":[104],"associated":[109,127,141,203],"area":[114],"under":[115],"curve":[118],"from":[119],"0":[120],"8":[122],"h.":[123],"Several":[124],"independently":[126],"variations":[129,220],"antituberculosis":[131,188,222],"identified:":[135],"human":[136],"immunodeficiency":[137],"virus":[138],"infection":[139],"39%":[143],"27%":[145],"reductions":[146],"rifampin":[148,157,165],"ethambutol,":[150],"respectively;":[151],"formulation":[152],"isoniazid":[159,167,179],"bioavailability;":[160],"female":[161],"had":[163,175,190],"increased":[164],"but":[169],"reduced":[170],"concentrations;":[172,193],"older":[173],"higher":[176],"levels":[177],"ethambutol;":[181],"history":[185],"previous":[187],"lower":[191],"dose":[196],"per":[197],"kilogram":[198],"body":[200],"weight":[201],"all":[208],"four":[209],"agents.":[210],"Further":[211],"studies":[212],"are":[213,231],"required":[214],"assess":[216],"implications":[218],"efficacy":[226],"safety":[228],"before":[229],"decisions":[230],"made":[232],"change":[234],"dosing":[236],"strategy":[237],"at":[240],"risk.":[241]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":15},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":15},{"year":2014,"cited_by_count":21},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":11}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}